← Back
Data updated: Mar 10, 2026
COPLEY PHARM
Immunology
COPLEY PHARM is a generic drug manufacturer focused on Immunology.
1985
Since
7
Drugs
-
Trials
53
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
AMITRIPTYLINE HYDROCHLORIDE 2026-01-09
Labeling
POTASSIUM CHLORIDE 2025-12-22
ALBUTEROL SULFATE 2025-12-01
ALBUTEROL SULFATE 2025-11-21
Labeling
POTASSIUM CHLORIDE 2025-11-20
POTASSIUM CHLORIDE 2025-10-27
Labeling
POTASSIUM CHLORIDE 2025-09-10
POTASSIUM CHLORIDE 2025-07-22
POTASSIUM CHLORIDE 2025-07-11
AMITRIPTYLINE HYDROCHLORIDE 2025-06-27
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (5)
Company Info
- First Approval
- 1985-10-08
- Latest
- 2006-01-23
- Applications
- 15